Photodynamic Therapy Overcoming the Hypoxia Microenvironment in Tumor Tissues-Juniper Publishers
Authored by Zheng Ruan
Abstract
Keywords: Photodynamic therapy; Bladder cancer; Boron-dipyrromethene
Abbreviations: PDT: Photodynamic Therapy; PS: Photo Sensitizers; ROS: Reactive Oxygen Species; ISC: Intersystem’s Crossing
Opinion
Photodynamic therapy (PDT) has been broadly exploited
as an substitute therapeutic for cancer treatment since it was first
allowed for the treatment of bladder cancer in 1993 [1]. It depends on
the ability of photo sensitizers (PS) to transfer energy from light
irradiation to tumor-dissolved oxygen (O2) to produce cytotoxic reactive oxygen species (ROS) for killing cells [2,3]. In the presence of molecular oxygen (O2), PS photo activation results in the creation of reactive oxygen species (ROS) like singlet oxygen (O2)
and damage to tumor tissues. Compared with other traditional cancer
therapies such as chemotherapy, PDT is invasive and negligibly toxic
[4]. Since treatment occurs only where light is delivered, it avoids
systematic treatment. Moreover, PDT can cause an inflammation immune
response and enlargement of anti-tumor immune surveillance. These
primary and secondary reaction mechanisms provide great inspiration for
developing PDT for cancer treatment [5].
First of all, the high efficiency of the PDT agent
itself should be emphasized. The photo sensitizer with higher singlet
oxygen quantum yield could yield more ROS after the same irradiation
condition. Many dyes obtained from natural or synthetic sources with
high intersystem’s crossing (ISC) which have been used for singlet
oxygen reactions. The heavy atom effect has been a valuable chemical
approach to increase ISC in several molecules including BODIPY
chromophores [6]. Regarding of that, we have designed and synthesized a
kind of boron-dipyrromethene derivative with bromine substituted
(BDP-Br) which has shown excellent ability of generating reactive oxygen
species (ROS) upon irradiation for PDT. Then, a simply PE Gylated
BDP-Br (PEG-BDP) as some kind of macro photo sensitizer was prepared
which has shown superior cellular uptake ability and high efficiency of
imaging and curing to PDT therapy in vitro and in vivo [7].
However, the direct therapeutic effect of PDT depend on ROS such as singlet oxygen (O2)
which has been still depend on oxygen supply in tissues [8]. Thus, a
major barrier in photodynamic therapy (PDT) for higher efficiency is
hypoxia environment in tumor area and PDT-induced incessant consumption
of oxygen. Owing to the abnormal new blood vessels and slack blood flow
in tumor tissues, there comes inequity between oxygen supply and cancer
cell oxygen consumption. Reported here to overcome this problem, we had
designed and synthesized an oxygen self-sufficient nanoparticles by
loading BODIPY into a water-dispersible fluorinated polypeptide drug
delivery platform for high efficiency PDT [9]. Since the ability of
higher oxygen capacity and O2 lifetime enhancement of
perfluorocarbon, comparing with non-fluorinated polymeric platform, the
whole PDT agent confirmed higher oxygen uptake and enhanced singlet
oxygen production, showing the prospective to increase the PDT efficacy
in hypoxic tumor environments after irradiation. Although the oxygen
content in tumor area remains inadequate during PDT, enough O2
can always be supplemented in the core of the nano carrier for
photodynamic depletion by the BODIPY inside. Therefore, we can obtain
enhanced PDT efficacy in vitro and in vivo which can overcome the limitation of hypoxia microenvironment in tumor areas in the clinical use of PDT
For more details Academic Journal of Polymer Science please
click on: https://juniperpublishers.com/ajop/index.php
To know more about PeerReview Academic Journal of Polymer Science (AJOP)
Comments
Post a Comment